Fate Therapeutics, Inc. short interest in 2022
In 2022, Fate Therapeutics, Inc.'s disclosed short interest ran from 12.23% of shares outstanding on 14 Jan 2022 to 22.98% on 30 Dec 2022, a change of +10.75 percentage points. The year's high was 22.98% on 30 Dec 2022 and its low 12.23% on 14 Jan 2022, averaging 19.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.54 days on 30 Nov 2022. Full history: Fate Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 12.23% (14 Jan 2022)
- End of year
- 22.98% (30 Dec 2022)
- Change
- +10.75 pp
- High
- 22.98% (30 Dec 2022)
- Low
- 12.23% (14 Jan 2022)
- Average
- 19.53%
- Highest days to cover
- 22.54 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 12.23% | 8.49 | |
| 31 Jan 2022 | 13.14% | 6.94 | |
| 15 Feb 2022 | 14.41% | 13.10 | |
| 28 Feb 2022 | 16.12% | 10.60 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 16.43% | 12.60 | |
| 31 Mar 2022 | 16.15% | 10.81 | |
| 14 Apr 2022 | 16.75% | 16.02 | |
| 29 Apr 2022 | 17.13% | 14.44 | |
| 13 May 2022 | 18.52% | 8.58 | 10-Q filed, results (8-K) |
| 31 May 2022 | 21.19% | 13.96 | |
| 15 Jun 2022 | 21.32% | 11.89 | |
| 30 Jun 2022 | 22.77% | 11.17 | |
| 15 Jul 2022 | 21.96% | 13.83 | |
| 29 Jul 2022 | 21.75% | 20.45 | |
| 15 Aug 2022 | 20.54% | 11.95 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 20.86% | 16.63 | |
| 15 Sep 2022 | 21.44% | 14.80 | |
| 30 Sep 2022 | 22.29% | 16.04 | |
| 14 Oct 2022 | 22.45% | 19.87 | |
| 31 Oct 2022 | 22.88% | 17.17 | |
| 15 Nov 2022 | 22.77% | 13.18 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 21.84% | 22.54 | |
| 15 Dec 2022 | 20.83% | 11.50 | |
| 30 Dec 2022 | 22.98% | 5.64 |
See also: Fate Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.